Altered Functional Mitochondrial Protein Levels in Plasma Neuron-Derived Extracellular Vesicles of Patients With Gadolinium Deposition (2022).

Download: https://www.frontiersin.org/journals/toxicology/articles/10.3389/ftox.2021.797496/full

Journal: Front. Toxicol, 11 January 2022 Sec. Neurotoxicology

Authors and Affiliations: Edward J Goetzl 1, Holden T Maecker 2, Yael Rosenberg-Hasson 2, Lorrin M Koran 3,*

1 School of Medicine, University of California San Francisco, San Francisco, CA, United States

2 Human Immune Monitoring Center, Microbiology and Immunology, Stanford University Medical Center, Stanford, CA, United States

3 Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, United States

Previous
Previous

The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposure (2023).

Next
Next

Commentary on the Association of Symptoms Associated With Gadolinium Exposure/Gadolinium Deposition Disease and Gadolinium-Based Contrast Agents (2022).